OS Therapies Inc. Files Definitive Proxy Statement
Ticker: OSTX · Form: DEF 14A · Filed: Feb 28, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | DEF 14A |
| Filed Date | Feb 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, sec-filing
TL;DR
OS Therapies DEF 14A filed. Get ready to vote on exec pay & board.
AI Summary
OS Therapies Inc. filed its definitive proxy statement on February 28, 2025, for its annual meeting of stockholders. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. Key details regarding executive compensation, director elections, and other corporate matters are expected to be disclosed.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not inherently present new financial risks.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- 20250228 (date) — Filing Date
- 20250331 (date) — Period of Report
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, also known as a definitive proxy statement, is filed by a company with the SEC to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When was this DEF 14A filing by OS Therapies Inc. made?
OS Therapies Inc. filed its definitive proxy statement on February 28, 2025.
What is the period of report for this filing?
The period of report for this filing is March 31, 2025.
What is the Central Index Key (CIK) for OS Therapies Inc.?
The Central Index Key (CIK) for OS Therapies Inc. is 0001795091.
What is the Standard Industrial Classification (SIC) code for OS Therapies Inc.?
The Standard Industrial Classification (SIC) code for OS Therapies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on February 28, 2025 regarding OS Therapies Inc (OSTX).